{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:35:44Z","timestamp":1777426544174,"version":"3.51.4"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003040","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:26:24Z","timestamp":1583432784000},"page":"e1003040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-6975","authenticated-orcid":true,"given":"Xin Hui S.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-5029","authenticated-orcid":true,"given":"Yan Naung","family":"Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-447X","authenticated-orcid":true,"given":"Ilsa L.","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jireh Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanghavie","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sompob","family":"Saralamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu Kiat S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-4822","authenticated-orcid":true,"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-820X","authenticated-orcid":true,"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Baiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter U.","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0062-2283","authenticated-orcid":true,"given":"Abdoulaye","family":"Djimde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-0317","authenticated-orcid":true,"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9649-4847","authenticated-orcid":true,"given":"Stephan","family":"Duparc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-1442","authenticated-orcid":true,"given":"Borimas","family":"Hanboonkunupakarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-5617","authenticated-orcid":true,"given":"Feiko O.","family":"ter Kuile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus V. G.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Nasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0745","authenticated-orcid":true,"given":"Fran\u00e7ois H.","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyprian O.","family":"Onyeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasithon","family":"Pukrittayakamee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-0294","authenticated-orcid":true,"given":"Andr\u00e9 M.","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-4030","authenticated-orcid":true,"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter R. J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wesche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2309-1171","authenticated-orcid":true,"given":"Nicholas P. J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-6112","authenticated-orcid":true,"given":"Christopher L-H","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":true,"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"pmed.1003040.ref001","unstructured":"World Health Organization. World Malaria Report 2019. Geneva, Switzerland: 2019."},{"key":"pmed.1003040.ref002","unstructured":"World Health Organization. Guidelines for the Treatment of Malaria. 3rd ed. Geneva, Switzerland. 2015."},{"key":"pmed.1003040.ref003","unstructured":"ICH Harmonised Tripartite Guideline E14. The Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Internet. 2005 [cited 2019 Dec 3]. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Guideline.pdf."},{"issue":"10","key":"pmed.1003040.ref004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"DM Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"pmed.1003040.ref005","unstructured":"World Health Organization. WHO Evidence Review Group on the Cardiotoxicity of Antimalarial Medicines. Geneva, Switzerland: 2017."},{"issue":"8","key":"pmed.1003040.ref006","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1473-3099(18)30297-4","article-title":"Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis","volume":"18","author":"XHS Chan","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pmed.1003040.ref007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"IL Haeusler","year":"2018","journal-title":"BMC Med"},{"issue":"9918","key":"pmed.1003040.ref008","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","journal-title":"Malaria. Lancet"},{"key":"pmed.1003040.ref009","first-page":"219","article-title":"Disease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria","volume":"13","author":"L Roggelin","year":"2014","journal-title":"PMCID"},{"issue":"5","key":"pmed.1003040.ref010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4269\/ajtmh.1997.56.494","article-title":"Prolongation of the QTc interval in African children treated for falciparum malaria","volume":"56","author":"L von Seidlein","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pmed.1003040.ref011","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcm.2017.07.012","article-title":"Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome","volume":"28","author":"AS Vink","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"pmed.1003040.ref012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"NJ White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003040.ref013","volume-title":"Stat\/Transfer: Data Conversion Software Utility","author":"Circle Systems Inc","year":"2017"},{"key":"pmed.1003040.ref014","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018"},{"issue":"1","key":"pmed.1003040.ref015","first-page":"1","article-title":"brms: An R Package for Bayesian Multilevel Models Using Stan","volume":"80","author":"P-C B\u00fcrkner","year":"2017","journal-title":"J StatSoftw"},{"key":"pmed.1003040.ref016","first-page":"76","article-title":"Stan: A probabilistic programming language","author":"B Carpenter","year":"2017","journal-title":"J Stati Softw."},{"key":"pmed.1003040.ref017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jclinepi.2017.04.023","article-title":"A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events","volume":"86","author":"JL Faillie","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pmed.1003040.ref018","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/ciw706","article-title":"Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial","volume":"64","author":"AM Siqueira","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pmed.1003040.ref019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12936-016-1084-1","article-title":"Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study","volume":"15","author":"N Valecha","year":"2016","journal-title":"Malar J"},{"issue":"8","key":"pmed.1003040.ref020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/cid\/ciw029","article-title":"A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa","volume":"62","author":"OA Toure","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pmed.1003040.ref021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","article-title":"Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial","volume":"16","author":"I Sagara","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003040.ref022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12879-016-1345-1","article-title":"The interaction between artemether-lumefantrine and lopinavir\/ritonavir-based antiretroviral therapy in HIV-1 infected patients","volume":"16","author":"T Kredo","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"10","key":"pmed.1003040.ref023","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1509150","article-title":"Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy","volume":"374","author":"A Kakuru","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pmed.1003040.ref024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12936-015-0982-y","article-title":"Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study","volume":"14","author":"OA Toure","year":"2015","journal-title":"Malar J"},{"issue":"4","key":"pmed.1003040.ref025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bcp.12680","article-title":"Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria","volume":"80","author":"B Darpo","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"pmed.1003040.ref026","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12936-015-0664-9","article-title":"Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim(R) (dihydroartemisinin\/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania","volume":"14","author":"R Baiden","year":"2015","journal-title":"Malar J"},{"issue":"6","key":"pmed.1003040.ref027","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/AAC.02794-13","article-title":"Pharmacokinetic interactions between primaquine and chloroquine","volume":"58","author":"S Pukrittayakamee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1003040.ref028","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/1475-2875-13-498","article-title":"Fixed dose artesunate amodiaquine\u2014a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine","volume":"13","author":"B Ogutu","year":"2014","journal-title":"Malar J"},{"issue":"12","key":"pmed.1003040.ref029","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1128\/AAC.03704-14","article-title":"Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects","volume":"58","author":"B Hanboonkunupakarn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pmed.1003040.ref030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cis475","article-title":"Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial","volume":"55","author":"N Valecha","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pmed.1003040.ref031","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1475-2875-10-237","article-title":"Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial","volume":"10","author":"JL Ndiaye","year":"2011","journal-title":"Malar J"},{"issue":"12","key":"pmed.1003040.ref032","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1128\/AAC.05265-11","article-title":"Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients","volume":"55","author":"T Kredo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pmed.1003040.ref033","doi-asserted-by":"crossref","first-page":"e11880","DOI":"10.1371\/journal.pone.0011880","article-title":"An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia","volume":"5","author":"N Valecha","year":"2010","journal-title":"PLoS ONE"},{"issue":"9","key":"pmed.1003040.ref034","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.01187-09","article-title":"New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine","volume":"54","author":"S Krudsood","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pmed.1003040.ref035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-009-0656-1","article-title":"Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers","volume":"65","author":"V Navaratnam","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"pmed.1003040.ref036","doi-asserted-by":"crossref","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","article-title":"Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial","volume":"4","author":"Q Bassat","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"pmed.1003040.ref037","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4269\/ajtmh.2007.77.447","article-title":"Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria","volume":"77","author":"OT Mytton","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pmed.1003040.ref038","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2125.2004.02087.x","article-title":"Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers","volume":"58","author":"PU Bassi","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pmed.1003040.ref039","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2125.2001.00351.x","article-title":"Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation","volume":"51","author":"DR Abernethy","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"pmed.1003040.ref040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0035-9203(00)90082-8","article-title":"Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria","volume":"94","author":"M van Vugt","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pmed.1003040.ref041","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.1999.60.936","article-title":"Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria","volume":"60","author":"M van Vugt","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pmed.1003040.ref042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199607113350202","article-title":"A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria","volume":"335","author":"TH Tran","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"pmed.1003040.ref043","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0035-9203(95)90094-2","article-title":"Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria","volume":"89","author":"RN Price","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8852","key":"pmed.1003040.ref044","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/0140-6736(93)92412-M","article-title":"Cardiac effects of antimalarial treatment with halofantrine","volume":"341","author":"F Nosten","year":"1993","journal-title":"Lancet"},{"issue":"23","key":"pmed.1003040.ref045","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198812083192301","article-title":"Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations","volume":"319","author":"NJ White","year":"1988","journal-title":"N Engl J Med"},{"issue":"8","key":"pmed.1003040.ref046","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1128\/AAC.00060-19","article-title":"Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults","volume":"63","author":"B Hanboonkunupakarn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pmed.1003040.ref047","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1473-3099(19)30156-2","article-title":"Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial","volume":"19","author":"R Ahmed","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pmed.1003040.ref048","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41598-018-37112-6","article-title":"Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation","volume":"9","author":"C Funck-Brentano","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pmed.1003040.ref049","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-017-0940-3","article-title":"A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria","volume":"15","author":"F Macintyre","year":"2017","journal-title":"BMC Med"},{"issue":"1","key":"pmed.1003040.ref050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/infdis\/jix110","article-title":"Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women","volume":"216","author":"P Natureeba","year":"2017","journal-title":"J Infect Dis"},{"key":"pmed.1003040.ref051","unstructured":"European Medicines Agency. Eurartesim 160\/20mg Tablets: Summary of Product Characteristics. Internet. 2011 [cited 2019 Dec 3]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001199\/WC500118113.pdf."},{"issue":"1","key":"pmed.1003040.ref052","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12936-017-2148-6","article-title":"Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children","volume":"16","author":"L Farrington","year":"2017","journal-title":"Malar J"},{"issue":"2","key":"pmed.1003040.ref053","first-page":"9","article-title":"Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon","volume":"6","author":"SL Oyegue-Liabagui","year":"2017","journal-title":"Am J Clin Exp Immunol"},{"issue":"22","key":"pmed.1003040.ref054","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1136\/heartjnl-2016-311079","article-title":"Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes","volume":"103","author":"PE Lazzerini","year":"2017","journal-title":"Heart"},{"issue":"12","key":"pmed.1003040.ref055","doi-asserted-by":"crossref","first-page":"e0208321","DOI":"10.1371\/journal.pone.0208321","article-title":"Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation","volume":"13","author":"AS Aromolaran","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"pmed.1003040.ref056","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0035-9203(96)90241-2","article-title":"Electrocardiographic monitoring in severe falciparum malaria","volume":"90","author":"DB Bethell","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 1","key":"pmed.1003040.ref057","first-page":"7","article-title":"Severe Malaria","volume":"19","author":"World Health Organization","year":"2014","journal-title":"Trop Med Int Health"},{"issue":"6","key":"pmed.1003040.ref058","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archinte.1986.00360180179026","article-title":"Fever and cardiac rhythm","volume":"146","author":"J Karjalainen","year":"1986","journal-title":"Arch Intern Med"},{"issue":"5","key":"pmed.1003040.ref059","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jelectrocard.2017.04.006","article-title":"The impact of fever on corrected QT interval","volume":"50","author":"D Drew","year":"2017","journal-title":"J Electrocardiol"},{"key":"pmed.1003040.ref060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphys.2017.00934","article-title":"In Vitro and In Silico Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details","volume":"8","author":"W Lee","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"pmed.1003040.ref061","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.111.060343","article-title":"An update on channelopathies: from mechanisms to management","volume":"127","author":"G Webster","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"pmed.1003040.ref062","first-page":"2552","article-title":"Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome","volume":"118","author":"AS Amin","year":"2008","journal-title":"J Clin Invest"},{"issue":"13","key":"pmed.1003040.ref063","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","article-title":"Clinical and genetic determinants of torsade de pointes risk","volume":"125","author":"AJ Sauer","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"pmed.1003040.ref064","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.111.023838","article-title":"Epidemiology and genetics of sudden cardiac death","volume":"125","author":"R Deo","year":"2012","journal-title":"Circulation"},{"key":"pmed.1003040.ref065","first-page":"353","article-title":"An Analysis of the Time Relations of Electrocardiograms","volume":"7","author":"HC Bazett","year":"1920","journal-title":"Heart"},{"key":"pmed.1003040.ref066","first-page":"489","article-title":"The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease","volume":"53","author":"LS Fridericia","year":"1920","journal-title":"Acta Med Scand"},{"issue":"12","key":"pmed.1003040.ref067","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1540-8167.2002.01211.x","article-title":"Linearly scaled, rate-invariant normal limits for QT interval: eight decades of incorrect application of power functions","volume":"13","author":"PM Rautaharju","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"pmed.1003040.ref068","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacep.2016.12.005","article-title":"A New QT Interval Correction Formulae to Adjust for Increases in Heart Rate","volume":"3","author":"SW Rabkin","year":"2017","journal-title":"JACC Clin Electrophysiol"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:27:02Z","timestamp":1583432822000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003040"}},"subtitle":[],"editor":[{"given":"James G.","family":"Beeson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003040","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]}}}